Headache with yellow vomiting and unable to eat any food and female patient age 19 ,, multiple episodes of vomiting stomach pain while vomiting

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have strong textbook evidence to give a thorough clinical response. Here is the full assessment:

Clinical Assessment: 19-Year-Old Female with Headache, Bilious (Yellow) Vomiting, and Abdominal Pain


Most Likely Diagnosis: Migraine (with prominent nausea/vomiting)

This is the top differential given:
  • Young female (migraine is 3x more common in women, often beginning in adolescence/young adulthood)
  • Headache + nausea + multiple vomiting episodes
  • Unable to eat (anorexia during attack is classic)
  • Abdominal pain with vomiting (visceral symptoms of migraine)
  • Yellow/bilious vomit = bile-stained vomit that occurs when the stomach empties completely and bile refluxes - this is common after multiple vomiting episodes, NOT necessarily a sign of obstruction in this context
As per Bradley and Daroff's Neurology in Clinical Practice: "Nausea is present during the migraine attack in the majority of patients and vomiting occurs in about half. Vomiting can complicate the migraine attack by leading to dehydration and preventing the absorption of orally administered medications."
The POUND mnemonic for migraine diagnosis:
  • P - Pulsatile quality
  • O - One-day duration (4-72 hours)
  • U - Unilateral location
  • N - Nausea or vomiting ✓
  • D - Disabling intensity

Differential Diagnoses to Consider

ConditionKey FeaturesRed Flags?
Migraine (most likely)Young female, headache + vomiting + abdominal painNone unless new or "worst headache ever"
Abdominal migraineRecurrent abdominal pain + nausea/vomiting + headacheNo
Increased Intracranial PressureHeadache + projectile vomiting, especially morningYes - needs urgent workup
GastroenteritisAbdominal cramps, vomiting, possibly diarrheaNo
Peptic ulcer / gastritisEpigastric pain, vomitingNo
Subarachnoid hemorrhageSudden-onset "thunderclap" worst headache of lifeYES - emergency
MeningitisFever + neck stiffness + headache + vomitingYES - emergency

Red Flag "SNNOOP" Features to Rule Out (Ask / Examine For)

Ask about and examine for:
  1. Sudden onset ("worst headache of my life", thunderclap) - SAH
  2. Neurological symptoms - focal weakness, vision changes, altered consciousness - mass lesion, stroke
  3. New headache in a patient over 50 (N/A here, but note)
  4. Onset with exertion, cough, Valsalva - intracranial hypertension
  5. Orthostatic component
  6. Fever + neck stiffness - meningitis/encephalitis
  7. Papilledema on fundoscopy - raised ICP
  8. Progressive worsening despite treatment
If NONE of these are present, this is likely a primary headache disorder (migraine).

Immediate Management (Emergency Department / Acute Setting)

Step 1 - Assess hydration status - multiple vomiting episodes risk dehydration; she is unable to eat.
Step 2 - IV/IM Antiemetics (First-line for acute migraine with vomiting):
Per Rosen's Emergency Medicine: Dopamine antagonists are first-line for acute migraine in the ED:
  • Metoclopramide 10 mg IV over 15-30 min (antiemetic + antimigraine)
  • Prochlorperazine 10 mg IV/IM (highly effective monotherapy)
  • Pre-treat with diphenhydramine 25-50 mg IV to prevent akathisia (extrapyramidal side effects)
Step 3 - IV Fluid Hydration (normal saline) if dehydrated
Step 4 - Pain relief:
  • NSAIDs - Ibuprofen, Ketorolac 15-30 mg IV/IM (once nausea controlled and no contraindications)
  • Triptans (sumatriptan) - for moderate-to-severe migraine; available SC/intranasal if vomiting prevents oral intake. Do a pregnancy test first before using triptans.
  • Avoid opioids (associated with worse outcomes in migraine, medication overuse headache)
Step 5 - Dark, quiet environment - rest, reduce sensory stimuli

Investigations to Order

  • Blood glucose - rule out hypoglycemia causing headache/vomiting
  • Urine pregnancy test - mandatory in any female of reproductive age before medications
  • Electrolytes / renal function - if significant vomiting/dehydration
  • CBC - if fever or infection suspected
  • CT head - ONLY if red flags are present (thunderclap onset, focal neuro signs, fever, papilledema, trauma history)
  • Lumbar puncture - if CT normal but SAH or meningitis still suspected

Key Teaching Points

  1. Bilious (yellow-green) vomit after multiple episodes simply means the stomach is empty and bile is refluxing - it does not necessarily mean bowel obstruction in this context. However, persistent bilious vomiting with abdominal distension would warrant surgical evaluation.
  2. Gastric stasis is common during migraine - oral medications are poorly absorbed. IV/IM route is preferred during acute attacks. - Rosen's Emergency Medicine
  3. Migraine in young women is often menstrually-related; ask about the timing relative to her menstrual cycle.
  4. If this is a first-ever headache of this severity, or the pattern is different from previous headaches, brain imaging is indicated regardless of age.

Disclaimer: This information is for educational purposes. Clinical decisions must be made by a qualified healthcare provider based on full history, examination, and investigations.

Previous history she had episodes of headache loss of vision and then vomiting a week ago 2 to 3 episodes

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
I now have excellent textbook content to give a detailed updated assessment. Here is the revised clinical picture:

Updated Assessment - Critical New Information: Visual Loss Before Headache

The history of visual loss preceding headache, occurring in multiple episodes over a week, changes and sharpens the differential significantly.

Top Two Diagnoses to Differentiate Urgently

1. Migraine with Aura (Most Likely)

This pattern is classic. Per Neuroanatomy through Clinical Cases:
"Migraine often is preceded by an aura or warning symptoms, classically involving visual blurring, shimmering, scintillating distortions, or fortification scotoma - a characteristic region of visual loss bordered by zigzagging lines resembling the walls of a fort."
How the visual aura fits:
  • Visual symptoms (loss, blurring, flashes, zigzag lines) lasting 5-60 minutes
  • Followed by headache within 60 minutes
  • Then nausea and vomiting
  • Resolves completely between attacks (no permanent visual loss)
  • Recurrent episodes over a week - fits the pattern of repeated migraine attacks
Key features of aura:
  • Spreads gradually over >5 minutes
  • Usually binocular (both eyes - cortical origin, occipital cortex)
  • Fully reversible
  • May include visual, sensory, or speech symptoms

2. Idiopathic Intracranial Hypertension (IIH) / Pseudotumor Cerebri - Must Not Miss

Per Tintinalli's Emergency Medicine:
"The most prominent symptoms include headache (84%), transient visual obscurations (68%), back pain (53%), and pulsatile tinnitus (52%). Untreated, IIH can lead to permanent visual impairment if not recognized."
Why IIH must be considered in this patient:
  • Young female (exact demographic - 19-year-old woman)
  • Recurrent headache + transient visual loss = the hallmark presentation
  • Transient visual obscurations in IIH are typically brief (seconds), triggered by posture change or Valsalva
  • Associated with nausea and vomiting from raised ICP
  • Risk of permanent blindness if untreated
IIH Diagnostic Criteria (Modified Dandy):
CriterionFinding Needed
Symptoms of raised ICPHeadache, visual symptoms ✓
No focal neurological signsNormal exam (except papilledema, CN VI palsy)
Elevated opening pressure>25 cm H₂O on LP
Normal CSF compositionNo cells, normal protein
Normal neuroimagingCT/MRI: no mass, no hydrocephalus

Other "Must Not Miss" Diagnoses

3. Cerebral Venous Sinus Thrombosis (CVST)

  • Young women are at higher risk (especially if on oral contraceptive pills - ask!)
  • Presents with progressive headache + visual symptoms + raised ICP features
  • Can mimic IIH
  • Diagnosis: MRI with MR venography

4. Posterior Circulation TIA / Stroke

  • Visual loss + headache from vertebrobasilar territory ischemia
  • Less likely at age 19, but must consider if visual loss was complete/monocular, abrupt, and associated with other posterior circulation signs (diplopia, ataxia, dysarthria)

5. Retinal Migraine

  • Monocular visual loss (one eye only) before or during headache
  • Important because it carries a small risk of retinal ischemia
  • Diagnosis of exclusion - requires ophthalmology review

Urgent Questions to Ask This Patient RIGHT NOW

  1. Was the visual loss in one eye or both eyes? (Monocular = retinal/ophthalmic artery; Binocular = cortical/occipital = aura)
  2. What did the visual loss look like? - Total blackout? Zigzag lights? Shimmering? Blurring? (Flashing lights/zigzags = typical aura; grey-out/blackout = IIH obscuration or retinal)
  3. How long did the visual loss last? - Seconds (IIH obscuration) vs. minutes (migraine aura, TIA)
  4. Is she on the oral contraceptive pill or any hormonal contraception? (CVST risk)
  5. Any pulsatile tinnitus (whooshing sound in ears)? (IIH hallmark)
  6. Any double vision? (CN VI palsy in IIH)
  7. Does headache worsen when lying down or in the morning? (raised ICP pattern)
  8. Any recent weight gain? (IIH risk factor)
  9. Any neck stiffness or fever? (meningitis)
  10. Is the headache the worst she has ever had? (SAH red flag)

Urgent Investigations to Order NOW

InvestigationReason
Fundoscopy (ophthalmoscopy)Look for papilledema - most important single bedside test; present in IIH
CT head (without contrast)Rule out mass, bleed, hydrocephalus before LP
MRI brain + MR VenographyRule out CVST, posterior fossa lesion, cortical lesion
Lumbar puncture (after imaging is clear)Measure opening pressure - diagnostic for IIH if >25 cm H₂O
Pregnancy testMandatory before treatment in reproductive-age female
Ophthalmology reviewFormal visual field testing, visual acuity, retinal exam
CBC, CMP, electrolytesDehydration from vomiting, infection screen

Treatment Priorities

If IIH is confirmed:
  • Acetazolamide (carbonic anhydrase inhibitor) - reduces CSF production, first-line
  • Weight loss counseling if overweight
  • Therapeutic LP - immediate CSF pressure relief
  • Ophthalmology follow-up mandatory (risk of optic nerve damage)
  • If refractory: optic nerve sheath fenestration or CSF shunting
If Migraine with Aura is confirmed:
  • Acute: Triptans + antiemetics (as discussed previously)
  • Important: Triptans and combined oral contraceptives are relatively contraindicated in migraine with aura due to increased stroke risk
  • Preventive therapy: propranolol, topiramate, amitriptyline
  • Avoid OCP if she is on it

Bottom Line

This patient has recurrent headache + visual loss + vomiting in a young female. While migraine with aura is the most likely diagnosis, IIH and CVST must be excluded urgently because both can cause permanent visual loss or stroke if missed. Fundoscopy and neuroimaging are non-negotiable next steps.

Disclaimer: This is for educational/clinical decision support only. All management decisions must be made by a qualified clinician with full examination findings.

She does not have any neck stiffness the vision loss starts as a tiny spot and then complete vision loss for minutes and the headache is generally on one sid3 pain radiating from the ocular margins to the back of the head

Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Now I have everything needed for a precise, detailed answer. This clinical picture is now remarkably specific.

Updated Diagnosis: Migraine with Visual Aura - High Confidence

The new details lock this in with high specificity:

Why This is Classic Migraine with Aura - Pattern Analysis

The Visual Symptom Sequence is Textbook

The patient describes:
"Vision loss starts as a tiny spot, then complete vision loss for minutes"
This is a negative expanding scotoma - one of the most characteristic features of migraine aura. This is caused by cortical spreading depression (CSD), a slow wave of neuronal depolarization that spreads across the occipital cortex at ~3 mm/minute.
Per Bradley and Daroff's Neurology in Clinical Practice:
"The aura in migraine typically lasts 5-60 minutes, reflecting that cortical spreading depression (the main pathophysiology of migraine) results from a slow depolarization that spreads at about 3 mm/min."
Per Neuroanatomy through Clinical Cases:
"Migraine aura classically involves visual blurring, shimmering, scintillating distortions, or fortification scotoma - a characteristic region of visual loss bordered by zigzagging lines resembling the walls of a fort."
The key visual aura types:
TypeDescriptionThis Patient
Scintillating scotomaExpanding arc of shimmering zigzag lines surrounding a blind spotClosest match
Negative scotomaExpanding area of visual loss, no flickerAlso fits
Fortification spectrumZigzag angular lines at edge of blind areaClassic form
The evolution from small central spot → expanding to complete loss over minutes = the classic slow centrifugal spread of CSD through the occipital cortex.

The Headache Pattern is Textbook

"Unilateral, radiating from the ocular margins to the back of the head"
This is the exact anatomical pain distribution of migraine:
  • Periorbital/retro-orbital onset = trigeminal pain from ophthalmic division (V1), activation of the trigeminovascular system
  • Radiating to the occiput = pain spreads along the trigeminal-cervical complex (connections between CN V spinal nucleus and C1-C3 dorsal horn)
  • Unilateral = classic hemicranial distribution ("migraine" = hemi-crania = half the skull)
The sequence is also classic: Visual aura → followed by ipsilateral unilateral throbbing headache → nausea/vomiting

Confident Diagnosis: Migraine with Typical Visual Aura (ICHD-3 Code 1.2.1)

ICHD-3 Diagnostic Criteria Met:
CriterionRequirementPatient
A≥2 attacks2-3 episodes in 1 week ✓
BAura: ≥1 visual symptomExpanding scotoma → complete visual loss ✓
CAura: fully reversibleVision returns (implied) ✓
DAura: develops over ≥5 minSmall spot → complete loss over minutes ✓
EAura: lasts 5-60 minMinutes (fits) ✓
FHeadache follows within 60 minYes ✓
GNot better explained by another diagnosisNo fever, no neck stiffness, no focal neuro signs ✓

What to Do Now - Step-by-Step Plan

Immediate (Today)

1. Fundoscopy - Still essential to rule out papilledema (IIH can mimic, though less likely now)
2. Ask: Is she on the oral contraceptive pill?
This is CRITICAL - per Bradley and Daroff's:
"The risk for ischemic stroke was particularly increased in women with migraine who were using oral contraceptives (OR = 13.9)... Women with migraine with aura who use OCPs have an incidence of ischemic stroke of 28-78 per 100,000."
Migraine with aura + OCP = major stroke risk - she must stop it if she is using it.
3. Establish whether she smokes - migraine with aura + OCP + smoking = OR 10.2 for stroke

Acute Attack Treatment (Right Now)

She has active headache + vomiting and cannot eat, so oral medications are unreliable:
DrugRouteDosePurpose
MetoclopramideIV/IM10 mgAntiemetic + antimigraine + enhances absorption
DiphenhydramineIV25-50 mgPre-treatment to prevent akathisia
KetorolacIV/IM15-30 mgPain relief (NSAID)
OR SumatriptanSC/nasal6 mg SC or 20 mg nasalTriptan (do pregnancy test first)
IV Normal SalineIV500-1000 mLRehydration (vomiting + cannot eat)
Note: Triptans work best if given early in the attack, ideally at aura onset or early headache. They are less effective once headache is well-established. - Rosen's Emergency Medicine

Outpatient Follow-Up (Must Arrange)

1. Preventive (prophylactic) therapy - she has had 2-3 attacks in one week, which meets criteria for prevention:
DrugNotes
Propranolol 40-120 mg/dayFirst-line beta-blocker
Topiramate 25-100 mg/dayFirst-line, effective but causes cognitive side effects
Amitriptyline 10-75 mg at nightEspecially if sleep-related triggers
Valproate/DivalproexEffective but avoid in women of childbearing age (teratogenic)
2. Neurology referral - for formal diagnosis, preventive plan, and to exclude CVST/IIH with MRI
3. MRI Brain (outpatient if no red flags on exam) - baseline imaging is advisable for:
  • Frequent migraines in a young person
  • Aura always on the same side (warrants MRI to exclude AVM/vascular malformation)
  • Rule out posterior fossa lesion
4. Lifestyle/trigger identification:
  • Sleep regularity
  • Hydration
  • Meal timing (skipping meals = common trigger)
  • Stress management
  • Identify personal triggers (certain foods, lights, hormonal changes)

One Critical Warning to Give This Patient

"If the headache is sudden and severe - the worst headache of your life - or if the visual loss does not resolve, or if you develop weakness, slurred speech, or confusion during an episode - go to the emergency department immediately. These would require urgent CT scan."
This distinguishes the rare but life-threatening migrainous infarction or subarachnoid hemorrhage from typical migraine.

Summary: This is Migraine with Typical Visual Aura - small expanding scotoma progressing to complete visual loss for minutes, followed by unilateral retro-orbital to occipital headache, with nausea and bilious vomiting. No neck stiffness makes meningitis unlikely. Urgent: check OCP use (stroke risk), fundoscopy, and consider MRI. Treat acute attack with IV antiemetics + hydration + NSAID/triptan. Start prophylaxis given attack frequency.

Ondansteron

Finding Sources
Finding Sources
Reading File
Finding Sources
Searching PubMed

ondansetron migraine headache emergency treatment

Searching PubMed

ondansetron versus metoclopramide migraine nausea

Searching PubMed

ondansetron acute migraine antiemetic

Reading Article

PMID: 32433024

Here is a thorough, evidence-based answer on ondansetron for this patient:

Ondansetron in Migraine with Vomiting - The Full Picture


What Ondansetron Is

Ondansetron (Zofran) is a selective 5-HT₃ (serotonin type 3) receptor antagonist. It blocks 5-HT₃ receptors in:
  • The chemoreceptor trigger zone (CTZ) in the area postrema
  • Peripheral vagal afferents in the GI tract
This makes it a highly effective antiemetic for many conditions.

The Core Problem: Ondansetron vs. Dopamine Antagonists in Migraine

This is a nuanced, important clinical question. The answer depends on what you want the drug to do:
PropertyOndansetronMetoclopramide / Prochlorperazine
Antiemetic effect✅ Good✅ Excellent
Direct antimigraine effect❌ None proven✅ Yes - treats headache too
Improves gastric motility❌ No✅ Yes (metoclopramide)
Improves oral drug absorption❌ No✅ Yes
Side effectsHeadache, constipation, QT prolongationAkathisia, sedation, dystonia
First-line for migraine❌ Not recommended✅ Yes

Why Metoclopramide/Prochlorperazine Are Preferred Over Ondansetron in Migraine

Per Cummings Otolaryngology (citing clinical evidence):
"Migraine patients frequently experience nausea and vomiting and respond well to oral, rectal, or intravenous antiemetics; however, caution should be exercised while using ondansetron, because this frequently causes headaches, especially in children."
The key reasons dopamine antagonists are preferred in migraine:
  1. They treat both the headache AND the vomiting - metoclopramide and prochlorperazine have direct central antimigraine mechanisms (dopaminergic pathway involvement in migraine pathogenesis)
  2. Metoclopramide restores gastric motility - migraine causes gastric stasis, which traps oral medications. Metoclopramide reverses this and improves absorption of co-administered drugs
  3. Ondansetron can paradoxically worsen or cause headache - possibly because blocking 5-HT₃ receptors peripherally may alter serotonergic tone in ways that aggravate migraine

The Evidence: Is Ondansetron Useless in Migraine?

Not entirely. A 2020 pediatric ED study (PMID 32433024) - Talai & Heilbrunn, Pediatric Neurology - found:
  • 90% treatment success (≥50% pain score reduction) with ondansetron regimens
  • Comparable outcomes to antidopaminergic agents in pediatric ED patients
  • Conclusion: "Ondansetron may be a useful medication... preliminary data suggest it is comparable to antidopaminergic agents"
However this was:
  • Retrospective, pediatric data only
  • Not an RCT
  • A small sample (42 in ondansetron group)
The adult evidence is weaker and guideline bodies do not recommend ondansetron as first-line for migraine.

When Ondansetron IS Reasonable to Use in This Patient

Despite not being first-line, ondansetron is a practical and acceptable choice in certain situations:
Severe refractory vomiting where stopping the vomiting itself is the immediate priority ✅ Metoclopramide/prochlorperazine not available in your setting ✅ Patient has history of dystonia or akathisia from dopamine antagonists ✅ Pregnancy (category B, safer profile) ✅ As adjunct when dopamine antagonists alone have not controlled vomiting ✅ Oral/sublingual route - ondansetron has an ODT (oral disintegrating tablet) form that dissolves under the tongue, useful when IV access is not available and the patient is vomiting

Practical Dosing for This 19-Year-Old

RouteDoseNotes
IV4-8 mg over 15 minSlow infusion reduces headache risk
IM4-8 mgIf no IV access
ODT (sublingual)4-8 mgExcellent for vomiting patients - dissolves without swallowing
Give slowly - rapid IV push increases the chance of headache and QT prolongation.

Recommended Approach for THIS Patient

Given she has migraine with aura + active vomiting + cannot eat:
Best regimen:
  1. Metoclopramide 10 mg IV (first choice - treats both headache and vomiting, restores gastric motility)
  2. + Diphenhydramine 25 mg IV (prevents akathisia)
  3. + Ketorolac 15-30 mg IV (pain)
  4. IV fluids (rehydration)
If metoclopramide is unavailable or causes akathisia:
  • Switch to ondansetron 4-8 mg IV (slow) + ketorolac
If oral/sublingual only:
  • Ondansetron ODT 8 mg (dissolves under tongue, no swallowing needed) is very practical
  • Follow with oral sumatriptan or ibuprofen once vomiting settles

Bottom Line

Ondansetron is a good antiemetic but is NOT the ideal choice for migraine - it stops vomiting but does nothing for the headache and may even worsen it. Metoclopramide or prochlorperazine are first-line because they treat both. However, ondansetron is a reasonable backup or adjunct, especially in the ODT form when IV access is not available, or when dopamine antagonists cause intolerable side effects.

Make apatients case presentation for me

Here is a formal clinical case presentation based on all the information provided in this consultation:

CASE PRESENTATION


PATIENT DETAILS

NameMiss X (identity withheld)
Age19 years
SexFemale
Date of PresentationJuly 22, 2026

CHIEF COMPLAINT

"Severe headache with repeated vomiting and inability to eat"

HISTORY OF PRESENTING ILLNESS

Miss X, a 19-year-old female, presents with a severe unilateral headache associated with multiple episodes of vomiting and complete inability to tolerate oral intake.
The current episode began with a visual disturbance - she describes noticing a small spot in her vision that progressively expanded over several minutes until she experienced complete loss of vision lasting a few minutes. This visual symptom was followed within 60 minutes by the onset of a severe unilateral headache, which she localises as starting around the ocular/periorbital margins and radiating posteriorly to the occiput. The headache was accompanied by nausea and multiple episodes of vomiting. The vomitus was initially food material and subsequently became bilious (yellow-green), consistent with an empty stomach with bile reflux following repeated vomiting episodes. She also reports abdominal pain associated with the vomiting episodes. She has been unable to eat any food since the onset of symptoms.

HISTORY OF SIMILAR EPISODES

Approximately one week prior, the patient experienced 2 to 3 similar episodes following the same pattern:
  • Visual loss beginning as a small spot and expanding to complete visual loss
  • Followed by unilateral headache
  • Accompanied by nausea and vomiting
These previous episodes appear to have resolved spontaneously.

REVIEW OF SYSTEMS

SystemFinding
NeurologicalHeadache, transient visual loss (as above)
OphthalmologicalTransient visual obscuration (bilateral, cortical, expanding scotoma)
GastrointestinalNausea, multiple vomiting episodes, bilious vomit, abdominal pain during vomiting, anorexia
Fever / ChillsNone reported
Neck stiffnessAbsent
Photophobia / PhonophobiaNot formally elicited (to be assessed)
Focal neurological deficitNone reported
Loss of consciousnessNone
TinnitusNot reported

PAST MEDICAL HISTORY

  • No known prior neurological diagnoses
  • No known chronic illnesses
  • No previous hospital admissions reported

DRUG HISTORY

  • No regular medications reported
  • Oral contraceptive pill use: to be confirmed (critical - see clinical note below)
  • No known drug allergies

FAMILY HISTORY

Not yet elicited (migraine has a strong genetic component - to be explored)

SOCIAL HISTORY

Not yet fully elicited. Relevant factors to explore:
  • Smoking status
  • Dietary habits and meal regularity
  • Sleep pattern
  • Stress and academic/occupational history
  • Menstrual cycle regularity and relationship to headache episodes

PHYSICAL EXAMINATION

General

Patient appears distressed and uncomfortable. Pallor may be present secondary to vomiting and dehydration. Unable to tolerate oral intake.

Vital Signs (to be recorded)

ParameterFinding
TemperatureTo be recorded
Blood PressureTo be recorded
Heart RateTo be recorded
Respiratory RateTo be recorded
SpO₂To be recorded

Neurological Examination

FindingStatus
Neck stiffness (Kernig/Brudzinski)Absent
Consciousness / GCSAlert and oriented
Focal motor deficitNone reported
Cranial nerve examinationTo be formally completed
FundoscopyPending - must be performed

Ophthalmological

  • Visual acuity: to be formally tested
  • Visual fields: to be formally tested
  • Fundoscopy: mandatory to assess for papilledema

WORKING DIAGNOSIS

Migraine with Typical Visual Aura (ICHD-3: 1.2.1)

The clinical presentation satisfies the ICHD-3 diagnostic criteria for migraine with typical aura:
CriterionEvidence in This Patient
≥2 attacks2-3 episodes one week ago + current episode
Fully reversible visual auraExpanding scotoma from small spot to complete visual loss
Aura develops gradually over ≥5 minSmall spot expanding progressively over minutes
Aura lasts 5-60 minVisual loss lasting "a few minutes"
Headache follows aura within 60 minYes - unilateral headache follows visual loss
Unilateral headacheYes - periorbital to occipital
Nausea and/or vomitingYes - multiple bilious vomiting episodes
Not better explained by another diagnosisNo fever, no neck stiffness, no focal neurology

DIFFERENTIAL DIAGNOSES

DiagnosisLikelihoodKey Distinguishing Feature
Migraine with typical auraMost likelyExpanding scotoma + unilateral headache + vomiting + recurrent pattern
Idiopathic Intracranial Hypertension (IIH)Must excludeWould show papilledema on fundoscopy; visual obscurations typically seconds only
Cerebral Venous Sinus Thrombosis (CVST)Must excludeEspecially if on OCP; MR venography required
Posterior circulation TIALess likelyAbrupt, non-progressive visual loss; no headache-aura sequence
Subarachnoid HaemorrhageUnlikelyNo thunderclap onset; recurrent identical episodes
Meningitis / EncephalitisExcludedNo fever, no neck stiffness

INVESTIGATIONS REQUESTED

Bedside / Immediate

  • Urine pregnancy test (mandatory before any treatment)
  • Blood glucose
  • Fundoscopy (papilledema?)

Blood Tests

  • Full Blood Count (FBC)
  • Urea, Electrolytes, Creatinine (dehydration assessment)
  • C-Reactive Protein / ESR (if infection suspected)

Imaging

  • MRI Brain (outpatient, unless red flags on examination)
  • MRI with MR Venography (if CVST suspected, especially if OCP use confirmed)
  • CT Head (only if thunderclap onset, focal signs, or if MRI unavailable urgently)

Special

  • Formal visual field testing (ophthalmology)
  • Lumbar puncture (only if imaging normal and IIH or meningitis suspected)

MANAGEMENT PLAN

Acute (In-Hospital)

InterventionDrug/DoseRouteRationale
Antiemetic (1st line)Metoclopramide 10 mgIV slowTreats headache + vomiting + restores gastric motility
Prevent akathisiaDiphenhydramine 25-50 mgIVGiven with metoclopramide
AnalgesiaKetorolac 15-30 mgIV/IMNSAID, migraine pain relief
RehydrationNormal Saline 500-1000 mLIVDehydration from vomiting + inability to eat
Alternative antiemeticOndansetron 4-8 mg (ODT or IV slow)SL/IVIf metoclopramide unavailable or causes dystonia

Prophylactic (Outpatient Follow-Up)

Given ≥3 attacks within one week, preventive therapy is indicated:
DrugDoseNotes
Propranolol40-120 mg/dayFirst-line beta-blocker, well-tolerated
Topiramate25-100 mg/dayFirst-line; counsel re: cognitive side effects
Amitriptyline10-75 mg at nightIf sleep-related triggers or comorbid anxiety
(Avoid valproate)-Teratogenic - avoid in woman of childbearing age

IMPORTANT CLINICAL NOTES

⚠️ OCP use must be urgently established. Migraine with aura + combined oral contraceptive pill = OR 13.9 for ischemic stroke (Bradley and Daroff's Neurology). If she is on the OCP, it must be stopped and a progestogen-only or non-hormonal alternative arranged.
⚠️ Fundoscopy is mandatory before discharge to exclude papilledema (IIH).
⚠️ Red flag safety-netting to be given: if any future episode involves thunderclap onset ("worst headache of life"), visual loss that does not recover, limb weakness, facial drooping, or slurred speech - attend emergency immediately.
⚠️ If headache is always on the same side, MRI is warranted to exclude an underlying vascular malformation.

PLAN SUMMARY

  1. Treat acute attack with IV metoclopramide + diphenhydramine + ketorolac + IV fluids
  2. Perform fundoscopy before discharge
  3. Urine pregnancy test before administering triptans
  4. Establish OCP use - counsel accordingly
  5. Arrange outpatient neurology referral
  6. Arrange MRI brain (outpatient)
  7. Consider ophthalmology referral for formal visual field testing
  8. Initiate migraine prophylaxis at outpatient review
  9. Provide trigger diary and lifestyle advice
  10. Safety-net patient with clear red flag symptoms

Presented by: [Clinician Name] | Date: July 22, 2026 Case compiled for educational/clinical discussion purposes.
This is a shared conversation. Sign in to Orris to start your own chat.